Effects of Sigma-1 Receptor Ligands on Peripheral Nerve Regeneration.

BD1063 PRE-084 Sig-1R KO electrophysiology intra-epidermal nerve fibers macrophage myelinated axons regeneration nociception peripheral nerve injury sigma-1 receptor

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
23 03 2022
Historique:
received: 03 03 2022
revised: 20 03 2022
accepted: 22 03 2022
entrez: 12 4 2022
pubmed: 13 4 2022
medline: 14 4 2022
Statut: epublish

Résumé

Peripheral nerve injuries lead to the loss of motor, sensory and autonomic functions in the territories supplied by the injured nerve. Currently, nerve injuries are managed by surgical repair procedures, and there are no effective drugs in the clinic for improving the capacity of axonal regeneration. Sigma-1 receptor (Sig-1R) is an endoplasmic reticulum chaperon protein involved in many functions, including neuroprotection and neuroplasticity. A few previous studies using Sig-1R ligands reported results that suggest this receptor as a putative target to enhance regeneration. The aim of this study was to evaluate the possible effects of Sig-1R ligands on axonal regeneration in a sciatic nerve section and repair model in mice. To this end, mice were treated either with the Sig-1R agonist PRE-084 or the antagonist BD1063, and a Sig-1R knock-out (KO) mice group was also studied. The electrophysiological and histological data showed that treatment with Sig-1R ligands, or the lack of this protein, did not markedly modify the process of axonal regeneration and target reinnervation after sciatic nerve injury. Nevertheless, the nociceptive tests provided results indicating a role of Sig-1R in sensory perception after nerve injury, and immunohistochemical labeling indicated a regulatory role in inflammatory cell infiltration in the injured nerve.

Identifiants

pubmed: 35406646
pii: cells11071083
doi: 10.3390/cells11071083
pmc: PMC8998141
pii:
doi:

Substances chimiques

Ligands 0
Receptors, sigma 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Neurotherapeutics. 2012 Oct;9(4):814-26
pubmed: 22935988
Front Pharmacol. 2019 Jun 12;10:613
pubmed: 31263413
Mediators Inflamm. 2015;2015:265056
pubmed: 26696751
Br J Pharmacol. 2021 Mar;178(6):1336-1352
pubmed: 32761823
Front Cell Neurosci. 2018 Sep 20;12:314
pubmed: 30294261
Brain Res Bull. 2015 Oct;119(Pt A):93-100
pubmed: 26434709
Exp Neurol. 2014 May;255:1-11
pubmed: 24552688
Expert Opin Drug Discov. 2021 Apr;16(4):373-389
pubmed: 33070647
J Neuropathol Exp Neurol. 2018 Jul 1;77(7):577-597
pubmed: 29767748
Biosci Biotechnol Biochem. 2019 Apr;83(4):659-665
pubmed: 30543144
Drug Dev Res. 2021 Apr;82(2):267-277
pubmed: 33051885
Eur J Pharmacol. 2019 Jun 15;853:129-135
pubmed: 30902656
Psychopharmacology (Berl). 2014 Oct;231(19):3855-69
pubmed: 24639046
PLoS One. 2012;7(9):e45118
pubmed: 23028794
Neuroscience. 2009 Aug 4;162(1):31-8
pubmed: 19345724
Eur J Neurosci. 2016 Feb;43(3):271-86
pubmed: 26228942
J Med Chem. 2021 Jan 14;64(1):890-904
pubmed: 33372782
Eur J Neurosci. 2003 Oct;18(8):2188-96
pubmed: 14622179
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Sci Rep. 2016 Nov 25;6:37835
pubmed: 27886264
Cell Calcium. 2012 Jul;52(1):28-35
pubmed: 22502861
Eur J Pain. 2017 Jan;21(1):61-72
pubmed: 27341510
Pharmacol Res. 2021 Jan;163:105339
pubmed: 33276102
Mol Neurobiol. 2018 Apr;55(4):2840-2850
pubmed: 28455697
Adv Exp Med Biol. 2017;964:79-83
pubmed: 28315266
Front Pharmacol. 2021 Dec 10;12:780588
pubmed: 34955848
Neurotherapeutics. 2018 Jan;15(1):178-189
pubmed: 28924870
FASEB J. 2020 Apr;34(4):5951-5966
pubmed: 32157739
Crit Rev Biomed Eng. 2011;39(2):81-124
pubmed: 21488817
Eur J Pharmacol. 2013 Sep 15;716(1-3):78-93
pubmed: 23500210
CNS Neurosci Ther. 2017 Dec;23(12):930-939
pubmed: 28990373
J Biomed Sci. 2017 Sep 16;24(1):74
pubmed: 28917260
J Pain. 2012 Nov;13(11):1107-21
pubmed: 23063344
Cell. 2007 Nov 2;131(3):596-610
pubmed: 17981125
Int J Mol Sci. 2021 Jun 28;22(13):
pubmed: 34203381
J Neurotrauma. 2011 May;28(5):831-40
pubmed: 21332255
Pain. 2009 Jun;143(3):252-261
pubmed: 19375855
J Pharmacol Exp Ther. 2002 Mar;300(3):1070-4
pubmed: 11861817

Auteurs

Patrick Cottilli (P)

Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences, Universitat Autònoma de Barcelona, 01893 Bellaterra, Spain.
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.

Núria Gaja-Capdevila (N)

Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences, Universitat Autònoma de Barcelona, 01893 Bellaterra, Spain.
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.

Xavier Navarro (X)

Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences, Universitat Autònoma de Barcelona, 01893 Bellaterra, Spain.
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH